Australian researchers at the University of South Australia, in collaboration with Ferronova, are pioneering a quantum sensor-powered laparoscopic probe that…
Browsing: Clinical Updates
Innovative drug delivery systems like nanoparticles, hydrogels, and microgrippers are transforming gastrointestinal treatment—particularly for IBD—by enabling precise, sustained, and targeted…
Neurogastroenterology (NGE), the subspecialty focused on disorders of gut-brain interaction (DGBIs) such as IBS and chronic constipation, faces limited growth…
Teladoc Health has launched a next-generation Cardiometabolic Health Program aimed at preventing and managing diabetes, hypertension, and obesity by addressing…
Once hyped and then humbled, the microbiome therapeutics field is entering a promising new phase, driven by FDA approvals, improved…
mBIOTA Labs announced promising results from the first prospective clinical trial of its elemental diet, mBIOTA Elemental™, showing high effectiveness…
Key takeaways: Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who…
A new randomized clinical trial published in JAMA Network Open shows that a mailed fecal immunochemical test (FIT) outreach program…
This article explores how electronic health records (EHRs), while beneficial for data access and care coordination, contribute significantly to provider…
The FDA has approved the Rectal Expulsion Device (RED), developed at the University of Michigan by Drs. Eric Shah and…